Sunshine Biopharma, Inc. SBFM
Set alert
2.75 USD -0.18 -6.14%
At close
2.74 -0.01 -0.36%
Pre-market · Nov 3, 5:24 AM ET
2.66 Day range 2.96
2.58 52-week range 464.00
- YTD
- -98.88%
- 1 year
- -99.22%
- Open
- 2.91
- Prev close
- 2.93
- Mkt cap
- 2.09M
- Vol
- 67.80K
- Avg vol
- 304.35K
- EPS
- -189.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.66
- High
- 2.96
- Forward P/E
- 0.02
- Beta
- -1.04
- Short ratio
- 0.39
- Inst. own
- 1.84%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.80
- 200-d avg
- 25.68
- 1y target
- 300.00
Analyst view
Consensus: none
Price target (mean) 300.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 12.50M | +62.8% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 27.78M | +15.3% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 100.00M | +260.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Aegis Capital | Reiterated | Buy | Buy |
| Aug 7, 2023 | Aegis Capital | Initiated | — | Buy |